Biohax International adds strategic investment from Icon Capital Reserve.

Biohax International, a Helsingborg, Sweden-basedcompany developing human implantable, NFC-based chips, announced getting into a strategic investment agreement with Hong Kong-based company Icon Capital Reserve.

FInancial details of the deal were not disclosed.

Biohax (BHX), founded in 2013 and led by CEO Jowan Osterlund, builds human embeddable tech powered by blockchain offering sovereign identity and complete control over data and digital identity. The chip is implanted in the hand, between the thumb and index finger and operates as identification for cases like shopping.

Biohax has more than 4,000 users in Sweden and expanded operations to London, UK in 2018.